BIIB vs CBAT · P/E 21, rev $9.89B vs rev $176.6M
Biogen Inc (BIIB) versus CBAK Energy Technology Inc (CBAT) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
CBAK Energy Technology Inc (CBAT) is a electrical equipment & parts company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported CBAT revenue for 2024-12-31 was $176.6M. Net income was $9.6M. Revenue was down 13.6% from 2023-12-31 to 2024-12-31. CBAT currently screens at market cap $97.1M.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. CBAT currently screens at market cap $97.1M.
Not investment advice. Open the BIIB and CBAT stock pages for the full models.
Not investment advice.